机构

• 上海药物研究所 [13]
• 海洋研究所 [3]
• 上海生物化学与细胞生... [3]
• 合肥物质科学研究院 [3]
• 昆明植物研究所 [2]
• 生态环境研究中心 [2]
• 更多

采集方式

• OAI收割 [29]

内容类型

• 期刊论文 [29]

发表日期

• 2025 [1]
• 2024 [5]
• 2023 [1]
• 2022 [5]
• 2021 [2]
• 2020 [1]
• 更多

学科主题

• Biochemist... [1]
• Biochemist... [1]
• Cell Biolo... [1]
• Oncology [1]
• Oncology; ... [1]
• Pharmacolo... [1]
• 更多

筛选

浏览/检索结果: 共29条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序作者升序作者降序题名升序题名降序发表日期升序发表日期降序 Identification of RIPK3 as a target of flavonoids for anti-necroptosis in vitro 期刊论文  OAI收割 BIOORGANIC CHEMISTRY, 2025, 卷号: 161, 页码: 11 作者:  Xie, Hang;  Li, Wanchen;  Han, Xiaoyu;  Li, Minjun;  Zhao, Qiang   |  收藏  |  浏览/下载：16/0  |  提交时间：2025/07/25 RIPK3  Inhibitors  Flavonoids  Co-crystal structure  Anti-necroptosis effect   The Evolution and Biological Activity of Metazoan Mixed Lineage Kinase Domain-Like Protein (MLKL) 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 卷号: 25, 期号: 19, 页码: 12 作者:  Wang, Qingyue;  Yuan, Zihao;  Xu, Hang;  Chen, Yuan;  Sun, Li   |  收藏  |  浏览/下载：17/0  |  提交时间：2024/12/20 MLKL  necroptosis  evolution   Discovery and optimization of 3-(indolin-5-yloxy)pyridin-2-amine derivatives as potent necroptosis inhibitors 期刊论文  OAI收割 ARCHIV DER PHARMAZIE, 2024, 页码: 21 作者:  Lan, Yaohan;  Ji, Yinchun;  Peng, Xia;  Duan, Wenhu;  Geng, Meiyu   |  收藏  |  浏览/下载：18/0  |  提交时间：2024/08/22 autoimmune disease  necroptosis inhibitor  pharmacokinetic profile  receptor interacting protein kinase 1 (RIPK1)  structural optimization   Editorial: Programmed cell death in aquatic animals 期刊论文  OAI收割 FRONTIERS IN IMMUNOLOGY, 2024, 卷号: 15, 页码: 2 作者:  Wang, Qingchao;  Yang, Dahai;  Zhang, Linlin;  Powell, Madison;  Lin, Yu-Hung   |  收藏  |  浏览/下载：26/0  |  提交时间：2024/09/02 programmed cell death  apoptosis  necroptosis  FAS/FASL  MLKL   Paralichthys olivaceus MLKL-mediated necroptosis is activated by RIPK1/3 and involved in anti-microbial immunity 期刊论文  OAI收割 FRONTIERS IN IMMUNOLOGY, 2024, 卷号: 15, 页码: 11 作者:  Hao, Kangwei   |  收藏  |  浏览/下载：50/0  |  提交时间：2024/04/07 Paralichthys olivaceus  necroptosis  RIPK1  RIPK3  MLKL  immune defense   Structure-based development of potent and selective type-II kinase inhibitors of RIPK1 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2024, 卷号: 14, 期号: 1, 页码: 319-334 作者:  Qin, Ying;  Li, Dekang;  Qi, Chunting;  Xiang, Huaijiang;  Meng, Huyan   |  收藏  |  浏览/下载：45/0  |  提交时间：2024/03/06 RIPK1  Necroptosis  Type-II kinase inhibitors  Rational design  Lead optimization  Structure-activity relationship  Anti-inflammation  Preclinical drug discovery   Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect 期刊论文  OAI收割 FRONTIERS IN PHARMACOLOGY, 2023, 卷号: 14, 页码: 1219362 作者:     |  收藏  |  浏览/下载：27/0  |  提交时间：2024/05/09 Erigeron breviscapus injection  Dengzhanxixin  Erigeron breviscapus (Vant  ) Hand  -Mazz  colorectal cancer  necroptosis  drug resistance  TUMOR-NECROSIS-FACTOR  COLORECTAL-CANCER  NATURAL COMPOUNDS  SCUTELLARIN  APOPTOSIS  PROLIFERATION  MACROPHAGES  MIGRATION  INVASION  THERAPY   Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Wang, Zuo-wei;  Zou, Feng-ming;  Wang, Ao-li;  Yang, Jing;  Jin, Rui   |  收藏  |  浏览/下载：52/0  |  提交时间：2022/12/22 AZD4547  RIPK1  inhibitors  SIRS model  anti-necroptosis   The pathogenesis of organ fibrosis: Focus on necroptosis 期刊论文  OAI收割 BRITISH JOURNAL OF PHARMACOLOGY, 2022 作者:  Hao, Min;  Han, Xin;  Yao, Zhouhui;  Zhang, Han;  Zhao, Mengting   |  收藏  |  浏览/下载：79/0  |  提交时间：2022/12/22 liver fibrosis  lung fibrosis  MLKL  necroptosis  RIPK1  3  tissue fibrosis   Alteration of intestinal microecology by oral antibiotics promotes oral squamous cell carcinoma development 期刊论文  OAI收割 MOLECULAR IMMUNOLOGY, 2022, 卷号: 149, 期号: 0, 页码: 94-106 作者:  Wei, Wei;  Li, Jia;  Liu, Fan;  Wu, Miaomiao;  Xiong, Kaixin   |  收藏  |  浏览/下载：44/0  |  提交时间：2022/11/09 CANCER  TYROSINE  METABOLISM  OPPORTUNITIES  NECROPTOSIS  MICROBIOME  DISEASE  VACCINE  HEAD